July 9th 2025
Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.
From Pain to Pimples: The Growing List of Topical Cannabinoid Applications
May 6th 2025Topically applied cannabinoids such as CBD and THC may offer significant benefits for people experiencing localized pain and dermatological conditions. This article explores these potential benefits as well as their mechanisms.
Cannabinoid Ethers: Identification, Binding Interactions, and their ADME Properties
June 28th 2024This review highlights an in-silico assessment of the binding interactions of pro-drug moiety analogs and an importance in identifying potential issues that would need further testing to ensure safety for consumers such as the hERG values which are pertinent in the pharmaceutical fields in whether or not drugs can be safe to use.
Chronic Pain Research Endeavors: How an App and University Are Presenting Real-World Patient Data
September 23rd 2022One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.